P12104 (FABPI_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 124.
History...
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Fatty acid-binding protein, intestinal Alternative name(s): Fatty acid-binding protein 2 Intestinal-type fatty acid-binding protein Short name=I-FABP | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 132 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | FABP are thought to play a role in the intracellular transport of long-chain fatty acids and their acyl-CoA esters. FABP2 is probably involved in triglyceride-rich lipoprotein synthesis. Binds saturated long-chain fatty acids with a high affinity, but binds with a lower affinity to unsaturated long-chain fatty acids. FABP2 may also help maintain energy homeostasis by functioning as a lipid sensor. |
| Subcellular location | |
| Tissue specificity | Expressed in the small intestine and at much lower levels in the large intestine. Highest expression levels in the jejunum. Ref.4 |
| Induction | By EGF. Ref.5 |
| Domain | Forms a beta-barrel structure that accommodates the hydrophobic ligand in its interior. |
| Sequence similarities | Belongs to the calycin superfamily. Fatty-acid binding protein (FABP) family. |
Ontologies
| Keywords | |
|---|---|
| Biological process | Transport |
| Cellular component | Cytoplasm |
| Coding sequence diversity | Polymorphism |
| Ligand | Lipid-binding |
| PTM | Acetylation |
| Technical term | 3D-structure Complete proteome Reference proteome |
| Gene Ontology (GO) | |
| Biological_process | digestion Traceable author statement Ref.9. Source: ProtInc fatty acid metabolic processInferred from electronic annotation. Source: Compara intestinal absorptionInferred from electronic annotation. Source: Compara |
| Cellular_component | apical cortex Inferred from electronic annotation. Source: Compara microvillusInferred from electronic annotation. Source: Compara plasma membraneInferred from electronic annotation. Source: Compara |
| Molecular_function | fatty acid binding Traceable author statement Ref.1. Source: ProtInc long-chain fatty acid transporter activityInferred from electronic annotation. Source: Compara |
| Complete GO annotation... | |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | |||||||||||||||||||||||||||||||
Molecule processing | ||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Initiator methionine | 1 | 1 | Removed By similarity | |||||||||||||||||||||||||||||||||
| Chain | 2 – 132 | 131 | Fatty acid-binding protein, intestinal | PRO_0000067328 | ||||||||||||||||||||||||||||||||
Sites | ||||||||||||||||||||||||||||||||||||
| Binding site | 83 | 1 | Fatty acid By similarity | |||||||||||||||||||||||||||||||||
| Binding site | 107 | 1 | Fatty acid By similarity | |||||||||||||||||||||||||||||||||
Amino acid modifications | ||||||||||||||||||||||||||||||||||||
| Modified residue | 2 | 1 | N-acetylalanine By similarity | |||||||||||||||||||||||||||||||||
Natural variations | ||||||||||||||||||||||||||||||||||||
| Natural variant | 55 | 1 | A → T in 29% of the population; 2-fold greater affinity for long-chain fatty acids; increased fat oxidation and insulin resistance. Ref.3 Ref.8 Ref.9 Ref.10 Corresponds to variant rs1799883 [ dbSNP | Ensembl ]. | VAR_002379 | ||||||||||||||||||||||||||||||||
Experimental info | ||||||||||||||||||||||||||||||||||||
| Mutagenesis | 39 | 1 | L → G: Reduced stability. Ref.6 | |||||||||||||||||||||||||||||||||
| Mutagenesis | 64 | 1 | E → G: Localized reduction in stability. Ref.6 | |||||||||||||||||||||||||||||||||
| Mutagenesis | 65 | 1 | L → A: Reduced stability. Ref.6 | |||||||||||||||||||||||||||||||||
| Mutagenesis | 65 | 1 | L → G: Reduced stability. Ref.6 | |||||||||||||||||||||||||||||||||
| Mutagenesis | 67 | 1 | V → G: Localized reduction in stability. Ref.6 | |||||||||||||||||||||||||||||||||
| Mutagenesis | 90 | 1 | L → G: Reduced stability. Ref.6 | |||||||||||||||||||||||||||||||||
| Mutagenesis | 123 | 1 | V → G: Reduced stability. Ref.6 | |||||||||||||||||||||||||||||||||
Secondary structure | ||||||||||||||||||||||||||||||||||||
Helix Strand Turn | ||||||||||||||||||||||||||||||||||||
| Beta strand | 5 – 14 | 10 | ||||||||||||||||||||||||||||||||||
| Helix | 15 – 22 | 8 | ||||||||||||||||||||||||||||||||||
| Helix | 26 – 32 | 7 | ||||||||||||||||||||||||||||||||||
| Turn | 33 – 35 | 3 | ||||||||||||||||||||||||||||||||||
| Beta strand | 38 – 44 | 7 | ||||||||||||||||||||||||||||||||||
| Beta strand | 47 – 53 | 7 | ||||||||||||||||||||||||||||||||||
| Beta strand | 58 – 64 | 7 | ||||||||||||||||||||||||||||||||||
| Beta strand | 69 – 72 | 4 | ||||||||||||||||||||||||||||||||||
| Beta strand | 74 – 76 | 3 | ||||||||||||||||||||||||||||||||||
| Beta strand | 78 – 86 | 9 | ||||||||||||||||||||||||||||||||||
| Beta strand | 89 – 96 | 8 | ||||||||||||||||||||||||||||||||||
| Turn | 97 – 99 | 3 | ||||||||||||||||||||||||||||||||||
| Beta strand | 102 – 110 | 9 | ||||||||||||||||||||||||||||||||||
| Beta strand | 113 – 120 | 8 | ||||||||||||||||||||||||||||||||||
| Beta strand | 123 – 131 | 9 | ||||||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "The human and rodent intestinal fatty acid binding protein genes. A comparative analysis of their structure, expression, and linkage relationships." Sweetser D.A., Birkenmeier E.H., Klisak I.J., Zollman S., Sparkes R.S., Mohandas T., Lusis A.J., Gordon J.I. J. Biol. Chem. 262:16060-16071(1987) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]. |
| [2] | "Generation and annotation of the DNA sequences of human chromosomes 2 and 4." Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L., Du H. Wilson R.K.Nature 434:724-731(2005) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [3] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], VARIANT THR-55. |
| [4] | "Intestinal-type and liver-type fatty acid-binding protein in the intestine. Tissue distribution and clinical utility." Pelsers M.M.A.L., Namiot Z., Kisielewski W., Namiot A., Januszkiewicz M., Hermens W.T., Glatz J.F.C. Clin. Biochem. 36:529-535(2003) [PubMed] [Europe PMC] [Abstract] Cited for: TISSUE SPECIFICITY. |
| [5] | "Epidermal growth factor regulates fatty acid uptake and metabolism in Caco-2 cells." Darimont C., Gradoux N., de Pover A. Am. J. Physiol. 276:G606-G612(1999) [PubMed] [Europe PMC] [Abstract] Cited for: INDUCTION BY EGF. |
| [6] | "Consequences of single-site mutations in the intestinal fatty acid binding protein." Rajabzadeh M., Kao J., Frieden C. Biochemistry 42:12192-12199(2003) [PubMed] [Europe PMC] [Abstract] Cited for: MUTAGENESIS OF LEU-39; GLU-64; LEU-65; VAL-67; LEU-90 AND VAL-123. |
| [7] | "Solution structure of human intestinal fatty acid binding protein: implications for ligand entry and exit." Zhang F., Luecke C., Baier L.J., Sacchettini J.C., Hamilton J.A. J. Biomol. NMR 9:213-228(1997) [PubMed] [Europe PMC] [Abstract] Cited for: STRUCTURE BY NMR. Tissue: Intestine. |
| [8] | "Solution structure of human intestinal fatty acid binding protein with a naturally-occurring single amino acid substitution (A54T) that is associated with altered lipid metabolism." Zhang F., Luecke C., Baier L.J., Sacchettini J.C., Hamilton J.A. Biochemistry 42:7339-7347(2003) [PubMed] [Europe PMC] [Abstract] Cited for: STRUCTURE BY NMR OF VARIANT THR-55. |
| [9] | "An amino acid substitution in the human intestinal fatty acid binding protein is associated with increased fatty acid binding, increased fat oxidation, and insulin resistance." Baier L.J., Sacchettini J.C., Knowler W.C., Eads J., Paolisso G., Tataranni P.A., Mochizuki H., Bennett P.H., Bogardus C., Prochazka M. J. Clin. Invest. 95:1281-1287(1995) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT THR-55. |
| [10] | "The association of Ala54Thr variant of intestinal fatty acid binding protein gene with general and regional adipose tissue depots." Kunsan X., Taisan Z., Weiping J., Duoqi S., Wei D., Jie L., Junxi L., Rong Z. Chin. Med. Sci. J. 14:46-51(1999) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT THR-55. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | M18079 Genomic DNA. Translation: AAA52417.1. AC092656 Genomic DNA. No translation available. BC069466 mRNA. Translation: AAH69466.1. BC069617 mRNA. Translation: AAH69617.1. BC069625 mRNA. Translation: AAH69625.1. BC069637 mRNA. Translation: AAH69637.1. BC111791 mRNA. Translation: AAI11792.1. | ||||||||||||||||||||||||||||||
| IPI | IPI00218477. | ||||||||||||||||||||||||||||||
| PIR | FZHUI. A29781. | ||||||||||||||||||||||||||||||
| RefSeq | NP_000125.2. NM_000134.3. | ||||||||||||||||||||||||||||||
| UniGene | Hs.282265. | ||||||||||||||||||||||||||||||
3D structure databases | |||||||||||||||||||||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||||||||||||||||||||
| ProteinModelPortal | P12104. | ||||||||||||||||||||||||||||||
| ModBase | Search... | ||||||||||||||||||||||||||||||
Protein-protein interaction databases | |||||||||||||||||||||||||||||||
| IntAct | P12104. 1 interaction. | ||||||||||||||||||||||||||||||
| STRING | 9606.ENSP00000274024. | ||||||||||||||||||||||||||||||
PTM databases | |||||||||||||||||||||||||||||||
| PhosphoSite | P12104. | ||||||||||||||||||||||||||||||
Polymorphism databases | |||||||||||||||||||||||||||||||
| DMDM | 119805. | ||||||||||||||||||||||||||||||
Proteomic databases | |||||||||||||||||||||||||||||||
| PaxDb | P12104. | ||||||||||||||||||||||||||||||
| PRIDE | P12104. | ||||||||||||||||||||||||||||||
Protocols and materials databases | |||||||||||||||||||||||||||||||
| DNASU | 2169. | ||||||||||||||||||||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||||||||||||||||||||
Genome annotation databases | |||||||||||||||||||||||||||||||
| Ensembl | ENST00000274024; ENSP00000274024; ENSG00000145384. | ||||||||||||||||||||||||||||||
| GeneID | 2169. | ||||||||||||||||||||||||||||||
| KEGG | hsa:2169. | ||||||||||||||||||||||||||||||
| UCSC | uc003icw.3. human. | ||||||||||||||||||||||||||||||
Organism-specific databases | |||||||||||||||||||||||||||||||
| CTD | 2169. | ||||||||||||||||||||||||||||||
| GeneCards | GC04M120238. | ||||||||||||||||||||||||||||||
| H-InvDB | HIX0004469. | ||||||||||||||||||||||||||||||
| HGNC | HGNC:3556. FABP2. | ||||||||||||||||||||||||||||||
| HPA | CAB047325. HPA034607. | ||||||||||||||||||||||||||||||
| MIM | 134640. gene. | ||||||||||||||||||||||||||||||
| neXtProt | NX_P12104. | ||||||||||||||||||||||||||||||
| PharmGKB | PA27957. | ||||||||||||||||||||||||||||||
| GenAtlas | Search... | ||||||||||||||||||||||||||||||
Phylogenomic databases | |||||||||||||||||||||||||||||||
| eggNOG | NOG295259. | ||||||||||||||||||||||||||||||
| HOGENOM | HOG000004829. | ||||||||||||||||||||||||||||||
| HOVERGEN | HBG005633. | ||||||||||||||||||||||||||||||
| InParanoid | P12104. | ||||||||||||||||||||||||||||||
| KO | K08751. | ||||||||||||||||||||||||||||||
| OrthoDB | EOG45TCPM. | ||||||||||||||||||||||||||||||
Gene expression databases | |||||||||||||||||||||||||||||||
| Bgee | P12104. | ||||||||||||||||||||||||||||||
| CleanEx | HS_FABP2. | ||||||||||||||||||||||||||||||
| Genevestigator | P12104. | ||||||||||||||||||||||||||||||
| GermOnline | ENSG00000145384. Homo sapiens. | ||||||||||||||||||||||||||||||
Family and domain databases | |||||||||||||||||||||||||||||||
| Gene3D | 2.40.128.20. 1 hit. | ||||||||||||||||||||||||||||||
| InterPro | IPR012674. Calycin. IPR011038. Calycin-like. IPR000463. Fatty_acid-bd. IPR000566. Lipocln_cytosolic_FA-bd_dom. [Graphical view] | ||||||||||||||||||||||||||||||
| Pfam | PF00061. Lipocalin. 1 hit. [Graphical view] | ||||||||||||||||||||||||||||||
| PRINTS | PR00178. FATTYACIDBP. | ||||||||||||||||||||||||||||||
| SUPFAM | SSF50814. Calycin. 1 hit. | ||||||||||||||||||||||||||||||
| PROSITE | PS00214. FABP. 1 hit. [Graphical view] | ||||||||||||||||||||||||||||||
| ProtoNet | Search... | ||||||||||||||||||||||||||||||
Other | |||||||||||||||||||||||||||||||
| BindingDB | P12104. | ||||||||||||||||||||||||||||||
| ChEMBL | CHEMBL4879. | ||||||||||||||||||||||||||||||
| ChiTaRS | FABP2. human. | ||||||||||||||||||||||||||||||
| EvolutionaryTrace | P12104. | ||||||||||||||||||||||||||||||
| GenomeRNAi | 2169. | ||||||||||||||||||||||||||||||
| NextBio | 8759. | ||||||||||||||||||||||||||||||
| SOURCE | Search... | ||||||||||||||||||||||||||||||
Entry information
| Entry name | FABPI_HUMAN | ||||||||
| Accession | Primary (citable) accession number: P12104 Secondary accession number(s): Q2NKJ1 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 4 Human chromosome 4: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with
